P. Markham

发表

Structural Basis of Multidrug Recognition by BmrR, a Transcription Activator of a Multidrug Transporter

R. Brennan, A. Neyfakh, E. Zheleznova, 1999, Cell.

Treatment of Ascites

P. Angeli, P. Markham, Jonathan Adams, 1974 .

IL-4 inhibits P-glycoprotein in normal and malignant NK cells.

A. Tambur, H. Gebel, P. Markham, 1998, Human immunology.

Mechanism of ligand recognition by BmrR, the multidrug-responding transcriptional regulator: mutational analysis of the ligand-binding site.

N. Vázquez-Laslop, A. Neyfakh, P. Markham, 1999, Biochemistry.

Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells

J. Coon, A. Chong, H. Gebel, 2005, Cancer Immunology, Immunotherapy.

Short communication Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells

J. Coon, H. Gebel, S. Bines, 1993 .

Inhibition of the Emergence of Ciprofloxacin Resistance in Streptococcus pneumoniae by the Multidrug Efflux Inhibitor Reserpine

P. Markham, 1999, Antimicrobial Agents and Chemotherapy.

Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus

A. Neyfakh, P. Markham, 1996, Antimicrobial agents and chemotherapy.

Multiple Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus

Michael E. Johnson, A. Neyfakh, P. Markham, 1999, Antimicrobial Agents and Chemotherapy.

Efflux-mediated drug resistance in Gram-positive bacteria.

A. Neyfakh, P. Markham, 2001, Current opinion in microbiology.

Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated

S. Taylor, N. Vázquez-Laslop, Maqbool Ahmed, 1995, Journal of bacteriology.

Multidrug resistance activity in human lymphocytes.

J. Coon, A. Chong, H. Gebel, 1991, Human Immunology.

A structure-based mechanism for drug binding by multidrug transporters.

R. Brennan, E. Bibi, R. Edgar, 2000, Trends in biochemical sciences.

Preliminary structural studies on the multi‐ligand‐binding domain of the transcription activator, BmrR, from bacillus subtilis

R. Brennan, A. Neyfakh, E. Zheleznova, 1997, Protein science : a publication of the Protein Society.

Efflux of the Natural Polyamine Spermidine Facilitated by the Bacillus subtilis Multidrug Transporter Blt*

N. Vázquez-Laslop, D. Woolridge, E. Gerner, 1997, The Journal of Biological Chemistry.

The drug-binding activity of the multidrug-responding transcriptional regulator BmrR resides in its C-terminal domain

M. Ahmed, A. Neyfakh, P. Markham, 1996, Journal of bacteriology.

Differential sensitivity of resting and IL-2 activated NK cells to R-verapamil.

A. Tambur, H. Gebel, T. Ellis, 1996, Transplantation.

Natural killer cell cytotoxicity and the multidrug resistance gene.

J. Coon, A. Chong, H. Gebel, 1993, Transplantation proceedings.

Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein.

T. Chambers, B. Zheng, H. Gebel, 1994, The Journal of biological chemistry.

Recognition of multiple drugs by a single protein: a trivial solution of an old paradox.

P N Markham, N. Vázquez-Laslop, R. Brennan, 2000, Biochemical Society transactions.

Crime laboratory proficiency testing results, 1978-1991, I: Identification and classification of physical evidence.

J L Peterson, P N Markham, J. Peterson, 1995, Journal of forensic sciences.

Crime laboratory proficiency testing results, 1978-1991, II: Resolving questions of common origin.

J L Peterson, P N Markham, J. Peterson, 1995, Journal of forensic sciences.